Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above
Clinical trial NCT05856084 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05856084
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-07
- Primary completion
- 2024-12-28
- Enrollment
- 924
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.